amikacin has been researched along with Urinary Tract Infections in 162 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 73 (45.06) | 18.7374 |
| 1990's | 19 (11.73) | 18.2507 |
| 2000's | 13 (8.02) | 29.6817 |
| 2010's | 36 (22.22) | 24.3611 |
| 2020's | 21 (12.96) | 2.80 |
| Authors | Studies |
|---|---|
| Alfa, M; Kibsey, P; Loo, V; McGeer, A; Nigrin, J; Peirano, G; Pienaar, C; Pitout, JD; Richardson, D; Toye, B | 1 |
| Blango, MG; Mulvey, MA | 1 |
| Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K | 1 |
| Ahmad, S; Ahmed, S; Ali, F; Farooq, M; Haq, I; Qureshi, SA; Rasheed, A; Sabir, MS; Shakeela, Q; Uzma, B | 1 |
| Abbas Tikki, K; Hayder Hasan, T; Sabah Bustani, G; Sadeq Al-Ethari, A | 1 |
| Abdul Ameer Al-Kraety, I; Ghani Al-Muhanna, S; Maki N Al-Muaala, A; Sadeq Yasir Al-Ethari, A | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Ge, H; Li, N; Yan, L; Zhang, Y | 1 |
| Ahmed, F; Akter, A; Alam, S; Jafar, T; Saha, O; Saha, SR; Sultana, KF | 1 |
| Cao, Y; Liu, C; Ren, H; Shang, Z; Wang, R; Xie, L; Yang, Y; Zhang, J | 1 |
| He, H; He, Q; Li, M; Lian, X; Liang, Y; Liao, X; Liu, Y; Long, T; Ren, H; Sun, J; Wei, Y; Zheng, Z; Zhong, Z; Zhou, S | 1 |
| Basmaci, R; Biscardi, S; Cohen, R; Dubos, F; Faye, A; Grimprel, E; Madhi, F; Raymond, J; Romain, AS; Ros, B; Rybak, A; Werner, A | 1 |
| Adeleke, G; Egbagbe, E; Ejembi, J; Ettu, AO; Habib, A; Irowa, OO; Makanjuola, OB; Medugu, N; Mutiu, B; Ogunbosi, B; Ogunsola, F; Oladele, RO; Osinaike, T; Rotimi, V; Uwaezuoke, NS | 1 |
| Essack, SY; Feldman, C; Maningi, NE; Mbelle, N; Modipane, L; Osei Sekyere, J | 1 |
| Baidya, R; Belbase, A; Dhakal, L; Govinda Prajapati, K; Kishor Bimali, N; Raya, S | 1 |
| Mandal, J; Sugathan, S | 1 |
| Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y | 1 |
| Altun, B; Cakar, A; Demirci-Duarte, S; Eser, OK; Gur, D; Sancak, B; Unalan-Altintop, T | 1 |
| Deepanjali, S; Jayakumar, I; Mandal, J; Mathaiyan, J; Sreenivasan, SK | 1 |
| Cui, ZH; Fang, LX; Li, XJ; Liao, XP; Liu, YH; Ni, WN; Sun, J; Tang, T; Yu, Y; Zheng, ZJ; Zhong, ZX; Zhou, YF | 1 |
| Arijs, I; Baten, E; Goethuys, H; Slabbaert, K; Van Der Aa, F; van Renterghem, K | 1 |
| Arouna, O; Ba Diallo, A; Camara, M; Deluca, F; Docquier, JD; Fall, B; Mboup, S | 1 |
| Béchet, S; Biscardi, S; Cohen, R; Madhi, F; Poey, N | 1 |
| Akhi, MT; Ghotaslou, R; Kafil, HS; Khalili, Y; Naghili, B; Sheikhalizadeh, V; Yousefi, S | 1 |
| Ali, I; Shabbir, M | 1 |
| Amasyali, AS; Erol, H; Kucukdurmaz, F; Sonmez, F; Yilmaz, D; Yilmaz, M | 1 |
| Amin, S; Dhrolia, MF; Mannan, A | 1 |
| Astroza, G; Catalán, M; Cerón, I | 1 |
| Béchet, S; Biscardi, S; Bonacorsi, S; Cixous, E; Cohen, R; Craiu, I; Dubos, F; Galerne, A; Grimprel, E; Hees, L; Hentgen, V; Jung, C; Levy, C; Lorrot, M; Madhi, F; Timsit, S | 1 |
| Polat, M; Tapisiz, A | 1 |
| Costa, AFP; Farias Filho, FT; Laudelino, JS; Santos, VM | 1 |
| Anastasiou-Katsiardani, A; Athanasopoulou, K; Barbouni, A; Basmaci, R; Folgori, L; Hsia, Y; Jackson, C; Tassiou, I; Vazouras, K; Velali, K; Zaoutis, T | 1 |
| Demir, M; Kazanasmaz, H | 1 |
| Gurbuz, Y; Korkmaz, N; Kul, G; Sandikci, F; Sencan, I; Tutuncu, EE | 1 |
| Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ | 1 |
| Athanasiou, S; Falagas, ME; Tansarli, GS | 1 |
| Baniel, J; Goldberg, H; Kedar, D; Mano, R; Stabholz, Y; Yossepowitch, O | 1 |
| Brodowska-Kania, D; Dubchak, I; Gomółka, M; Jurkiewicz, D; Niemczyk, S; Piechota, W; Rymarz, A; Szamotulska, K | 1 |
| Berk, H; Celik, O; Ipekci, T; Seyman, D | 1 |
| Cooke, K; Torres, AR | 1 |
| Aganj, M; Ali, L; Sakinc, T; Shokoohizadeh, L; Soleimani, N | 1 |
| Chen, PY; Chien, YL; Chou, CM; Fu, LS; Huang, CM; Huang, FL; Lin, CF; Wu, TH | 1 |
| Aubert, C; Barbar, S; Bastide, S; Elotmani, L; Lefrant, JY; Lloret, S; Molinari, N; Muller, L; Nucci, B; Polge, A; Pradel, G; Roberts, JA; Roger, C; Saissi, G | 1 |
| Amemoto, Y; Aoyama, T; Arakawa, S; Deguchi, T; Egawa, S; Fujimoto, Y; Fujisawa, M; Goto, H; Hamasuna, R; Hanaki, H; Hashimura, T; Hayami, H; Hirose, T; Ichikawa, T; Inatomi, H; Ishihara, S; Ishikawa, K; Ishitoya, S; Ito, N; Ito, T; Iwata, S; Kadota, J; Kagara, I; Kaku, M; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Kobuke, M; Koda, S; Komeda, H; Kumon, H; Kunishima, Y; Maeda, H; Matsubara, A; Matsuda, Y; Matsui, T; Matsukawa, M; Matsumoto, M; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Muranaka, T; Nakamura, I; Nishimura, K; Oka, H; Okumura, K; Onishi, H; Onodera, S; Sato, J; Shigeta, M; Sunakawa, K; Taguchi, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Togo, Y; Tsugawa, M; Tsukamoto, T; Uehara, S; Wakeda, H; Watanabe, A; Yamada, D; Yamamoto, S; Yamashita, M; Yasuda, M | 1 |
| Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S | 1 |
| Al-Moyed, KA; Al-Robasi, AB; Al-Shamahy, HA; Alyousefi, NA; Gondos, AS | 1 |
| Cho, SY; Choi, JH; Choi, SM; Lee, DG; Park, SH; Yoo, JH | 1 |
| Akamatsu, S; Iguchi, R; Ito, M; Ito, N; Kamiyama, Y; Kanamaru, S; Miyazaki, Y; Ogura, K; Sano, T; Sengiku, A; Takahashi, A; Takenawa, J | 1 |
| Ak, S; Ay Altıntop, Y; Balcı, PÖ; Budak, EE; Çalışkan, A; Çizmeci, Z; Çopur Çiçek, A; Fırat, M; Özgümüş, OB; Sancaktar, M; Sandallı, C; Sarı, F; Şay Coşkun, SU; Yağmur, G; Yıldız, N | 1 |
| Costa, SF; de Castro Lima, VA; de Maio Carrillho, CM; de Oliveira, LM; Gaudereto, JJ; Levin, AS; Martins, RC; Perozin, JS; Urbano, MR | 1 |
| Graiziger, CT; Khoruts, A; Sadowsky, MJ; Staley, C; Vaughn, BP | 1 |
| Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF | 1 |
| Alonso-Isa, M; Benítez-Sala, R; García-Rojo, E; Gil-Moradillo, J; González-Padilla, DA; Justo-Quintas, J; Lara-Isla, A; Medina-Polo, J; Passas-Martínez, JB; Sopeña-Sutil, R; Tejido-Sánchez, Á | 1 |
| Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P | 1 |
| Bavbek, N; Bayrak, O; Catal, F; Karabel, D; Karabel, M; Odemis, E; Uz, E | 1 |
| Gajardo S, C; Le Corre P, N; Montecinos B, C; Morales M, V; Peña D, A; Viviani S, T | 1 |
| Bahador, A; Dehghani, M; Emadmarvasti, V; Fathikalajahi, A; Kazemi, K; Malek-Hosseini, SA; Mohammadian, R; Nikeghbalian, S; Salahi, H; Salehipour, M | 1 |
| Batura, D; Bo Nielsen, P; Charlett, A; Rao, GG | 1 |
| Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW | 1 |
| Astal, Z; El-Manama, A; Sharif, FA | 1 |
| Derevianko, II | 1 |
| Anandkumar, H; Dayanand, A; Kapur, I | 1 |
| Güven, A | 1 |
| Krzeska, I | 1 |
| Grzegorzewska, AE; Tykarski, A; Wanic-Kossowska, M | 1 |
| Acar, B; Aysev, D; Ekim, M; Güriz, H; Kavaz, A; Ozçakar, ZB; Oztürk, B; Yalçinkaya, F; Yüksel, S | 1 |
| Cunha, BA | 1 |
| Adamski, R; Jankowski, S; Kłak, M; Wojnicz, D | 1 |
| Aksaranugraha, S; Kittisomprayoonkul, W; Suankratay, C; Sukonthamarn, K; Tantisiriwat, N; Tantisiriwat, W; Unhasuta, C | 1 |
| Alexiou, VG; Falagas, ME; Kremastinou, J; Marini-Mastrogiannaki, A; Polemis, M; Vatopoulos, AC | 1 |
| Anderson, H; Becerra, S; Godoy, J; Herrera, N; Jofre, M; Silva, J; Urdanivia, R | 1 |
| Falkiner, FR; Jacoby, GA; Keane, CT; McCann, SR | 1 |
| Catarinelli, L; Celi, F; Crapa, G; De Rosa, F; Frongillo, RF; Luzzi, L; Moretti, MV; Palumbo, M; Rossi, A; Sciannameo, F | 1 |
| Connor, E; Goessler, M; Wallen, L; Yogev, R; Zeller, WP | 1 |
| Alegente, G; Marchi, B; Pieri, I; Progenie, G; Rubino, M; Saturni, A | 1 |
| Jimenez, EM; Lindquist, LB; Montgomerie, JZ; Morrow, JW; Sapico, FL | 1 |
| Desmond, AD; Hart, CA; Percival, A | 1 |
| Baumueller, A; Frimodt-Møller, N; Hoyme, U; Lau, C; Madsen, PO; Maigaard, S; Nielsen, OS; Welling, PG | 1 |
| de Azevedo, TH; de Oliveira, MM; Rocha, H | 1 |
| Bock, BV; Edelstein, PH; Meyer, RD | 1 |
| Chikaoka, H; Fujii, N; Kojima, S; Nakazawa, S; Narita, A; Oka, S; Sato, H | 1 |
| Murahashi, I; Takasaki, E; Toyoda, A | 1 |
| Höffler, D | 2 |
| Le Noac'h, E; Le Roy, JP; Mahe, M; Plantin, P | 1 |
| Beuscart, C; Mouton, YJ | 1 |
| Sturm, W | 1 |
| Carbon, C | 1 |
| Cordonnier, C; Delain, M; Delmer, A; Gardembas, M; Gres, JJ; Herbrecht, R; Ladeb, S; Moreau, P; Nalet, V; Pico, JL; Rollin, C | 1 |
| Eltahawy, AT | 1 |
| Chankova, D; Guirguitzova, B; Minkov, N; Zozikov, B | 1 |
| Ballanger, P; Ragnaud, JM; Tauzin-Fin, P | 1 |
| Czinner, A; Katona, G | 1 |
| Chen, YS; Lee, SS; Lin, HH; Lin, WR; Liu, YC; Tsai, TH; Wann, SR; Yen, MY | 1 |
| Citak, A; Garratty, G; Karabocuoglu, M; Ucsel, R; Uzel, N | 1 |
| Baughman, KL; Edwards, CQ; Lietman, PS; Rogers, JF; Smith, CR | 1 |
| Craven, PC; Drutz, DJ; Jorgensen, JH; Kaspar, RL | 1 |
| Harrison, LH | 1 |
| Bint, AJ; Speller, DC; Stephens, M | 1 |
| Ichikawa, T; Kawada, Y; Kumamoto, Y; Nakano, I; Nishiura, T; Shishido, S; Tsuji, I | 1 |
| Armani, U; Astengo, F; Azzena, D | 1 |
| Agudelo, N; de Vidal, EL; Manotas, R; Ramirez, JI; Trujillo, H; Uribe, A; Zapata, CT; Zuluaga, AI | 1 |
| Appel, GB; Neu, HC | 1 |
| Frimodt-Möller, N; Madsen, PO; Maigaard, S | 1 |
| Federspil, P; Schätzle, W; Schindler, K; Tiesler, E; Weich, C; Ziegler, M | 1 |
| Bodey, GP; Feld, R; Rodriguez, V; Valdivieso, M | 1 |
| Ishigami, J; Kataoka, N; Mayumi, K; Mita, T | 1 |
| Alford, RH; Leonard, JM; McGee, ZA | 1 |
| Fu, KP; Jahre, JA; Neu, HC | 1 |
| Leidenfrost, U; Nöske, HD; Schröder, R; Sziegoleit, A; Weidner, W | 1 |
| Durand, L; Freydiere, AM; Gille, Y; Perrin, P; Vincent, P | 1 |
| Hayashi, I; Kaishio, K; Kawamorida, K; Konno, K; Kudo, S; Kurita, K; Nagai, K; Oizumi, K; Watanabe, A | 1 |
| Agbayani, MM; Jhaveri, RC; Khan, AJ | 1 |
| Iwao, N; Konya, H; Kuroda, J; Morita, M | 1 |
| Fuchs, P; Lüthy, R; Siegenthaler, W | 1 |
| Grunert, K; Koeppe, P; Langmaack, H; Lode, H | 2 |
| Hofstetter, A; Staehler, G | 1 |
| Cox, CE | 1 |
| Agre, K; Berman, E; Gooding, PG; Lane, AZ | 1 |
| Berger, J; Cates, CY; Fox, LM; Gurwith, MJ; Lank, BA; Mathias, RG; McCullough, DW; Ronald, AR; Stiver, HG | 1 |
| Marget, W; Reindke, B; Versmold, H | 1 |
| Doughty, SC; Greenberg, SB; Martin, RR | 1 |
| Eubanks, N; Gilbert, DN; Jackson, J | 1 |
| Hofstetter, A | 1 |
| Brumfitt, W; Daikos, GK; Hamilton-Miller, JM; Kosmidis, JC | 1 |
| Demers, HG; Höffler, D; Koeppe, P | 1 |
| Mazzei, T; Nicoletti, I; Paradiso, M; Periti, P | 1 |
| Dámaso, D; García-Iglesias, MC; Martínez-Beltrán, J; Moreno-López, M | 1 |
| Chang, CT; Evans, HE; Hochstein, L; Jhaveri, R; Khan, AJ | 1 |
| Eickhoff, TC; Iannini, PB; LaForce, FM | 1 |
| Carmalt, ED; Finegold, SM; Lewis, RP; Meyer, RD | 1 |
| Hirose, T; Kumamoto, Y; Tanaka, N; Yokoo, A | 1 |
| Bassaris, HP; Chryssanthopoulos, C; Melekos, MD; Skoutelis, A | 1 |
| Van der Auwera, P | 1 |
| Amprimo, MC; Caramalli, S; Cavalli, G; Franchino, L; Mantelli, M; Pollastrelli, E; Raiteri, F; Varese, LA | 1 |
| Karahan, M; Kiliç, H | 1 |
| Giamarellou, H; Moschovakis, E; Petrikkos, G; Sfikakis, P; Vavouraki, E; Voutsinas, D; Yiallouros, K | 1 |
| Citerio, P | 1 |
| Kamnev, IuV; Kuznetsova, SM; Sokolova, VI | 1 |
| Aydin, M; Dervişoğlu, AA; Unal, S | 1 |
| Bertrand, H; Boulanger-Ferre, F; Descottes, B; Desport, JC; Devalois, B; Mercury, P; Peze, P; Sardin, B | 1 |
| Abe, T; Misawa, S; Nakagawa, H; Nishigaki, H; Okuda, T; Takino, T; Tanaka, S; Taniwaki, M; Tsuda, S | 1 |
| Gonzales, C; Westblom, TU | 1 |
| Ibrahim, S; Meunier, F; Tulkens, PM; Van der Auwera, P | 1 |
| Bertelli, A; Bertelli, AA; Cirami, C; Giovannini, L; Marchitiello, M; Palla, R; Tuoni, M | 1 |
| Ansquer, M; Brun-Buisson, C; Duval, J; Legrand, P; Montravers, F; Philippon, A | 1 |
| Klastersky, J; Van der Auwera, P | 1 |
| Lees, GE; Rogers, KS; Simpson, RB | 1 |
| Baron, D; Cozian, A; Espaze, E; Juge, C; Lepage, JY; Reynaud, AE; Souron, R | 1 |
| Barclay, C; Casellas, J; Farinati, A; Hahn, LB; Iribarren, M; Traballi, C | 1 |
| Bergogne-Bérézin, E; Delcercq, D; Prokocimer, P; Serieys, C | 1 |
| Asano, Y; Imanaka, K; Koyanagi, T; Miyabe, N; Nagamori, S; Sakashita, S; Shinno, Y; Takahashi, Y; Tubo, S | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S; Okura, K | 1 |
| Holloway, WJ | 1 |
| Childs, SJ | 1 |
| Canawati, HN; Gilmore, DS; Graham, IE; Ibraham, MZ; Montgomerie, JZ; Morrow, JW | 1 |
| Rocca Rossetti, S | 1 |
| Carson, CC; Paulson, DF; Rudd, C | 1 |
| Garau, J; Javaloyas, M; Sanchez, C; Valverde, J | 1 |
| Graham, SD | 1 |
| Funai, K; Hayahara, N; Kishimoto, T; Maekawa, M; Nishijima, T; Nishio, S; Oshima, N; Sasaki, S; Wada, S; Yuki, K | 1 |
9 review(s) available for amikacin and Urinary Tract Infections
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Epidemiology of pathogens and antimicrobial resistance of nosocomial urinary tract infections in patients with spinal cord injuries in China: A systematic review and meta-analysis.
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Humans; Levofloxacin; Spinal Cord Injuries; Urinary Tract Infections | 2023 |
Antimicrobial treatment of urinary tract infections in children.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Child; Escherichia coli; Humans; Infant, Newborn; Urinary Tract Infections | 2023 |
Chryseobacterium gleum in a man with prostatectomy in Senegal: a case report and review of the literature.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Typing Techniques; Catheter-Related Infections; Catheters, Indwelling; Chryseobacterium; Device Removal; Fever; Flavobacteriaceae Infections; Humans; Hypertension; Male; Prostatectomy; Senegal; Treatment Outcome; Urinary Catheters; Urinary Tract Infections | 2017 |
Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa.
Topics: Africa; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Databases, Factual; Drug Evaluation; Enterobacteriaceae; Enterobacteriaceae Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections | 2013 |
New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited.
Topics: Amikacin; Cell Membrane; Colistin; Doxycycline; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Methicillin Resistance; Minocycline; Nitrofurantoin; Polymyxin B; Staphylococcal Infections; Urinary Tract Infections | 2006 |
[Recent views concerning urinary tract infections].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Sulfonamides; Urinary Tract Infections | 1978 |
Gentamicin in 1978.
Topics: Amikacin; Animals; Bacterial Infections; Drug Synergism; Ear Diseases; Gentamicins; Humans; Kidney; Kidney Diseases; Netilmicin; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Sisomicin; Tobramycin; Urinary Tract Infections | 1978 |
Pharmacokinetic evaluation of single daily dose amikacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Child; Child, Preschool; Drug Administration Schedule; Half-Life; Humans; Middle Aged; Penicillins; Prospective Studies; Urinary Tract Infections | 1991 |
35 trial(s) available for amikacin and Urinary Tract Infections
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Fluoroquinolones; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Single-Blind Method; Transurethral Resection of Prostate; Urinary Tract Infections | 2021 |
[In the search for effective and safe dose of amikacin in patients with chronic kidney disease].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Insufficiency, Chronic; Sepsis; Treatment Outcome; Urinary Tract Infections; Urine | 2014 |
A Prospective Randomized Trial Comparing a Combined Regimen of Amikacin and Levofloxacin to Levofloxacin Alone as Prophylaxis in Transrectal Prostate Needle Biopsy.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endosonography; Follow-Up Studies; Humans; Image-Guided Biopsy; Injections, Intravenous; Levofloxacin; Male; Prospective Studies; Prostate; Rectum; Single-Blind Method; Treatment Outcome; Urinary Tract Infections | 2016 |
[Treatment of urinary tract infections in febrile infants: experience of outpatient intravenous antibiotic treatment].
Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Female; Fever; Hospitalization; Humans; Infant; Infusions, Intravenous; Male; Medication Adherence; Prospective Studies; Time Factors; Treatment Outcome; Urinary Tract Infections | 2009 |
Is perioperative intravesically applied antibiotic solution effective in the prophylaxis of urinary tract infections after renal transplantation?
Topics: Administration, Intravesical; Adult; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Chi-Square Distribution; Double-Blind Method; Enterobacter; Escherichia coli; Female; Humans; Immunosuppressive Agents; Incidence; Iran; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Perioperative Care; Prospective Studies; Pseudomonas aeruginosa; Time Factors; Treatment Outcome; Urinary Tract Infections; Young Adult | 2010 |
Single-dose amikacin treatment of first childhood E. coli lower urinary tract infections.
Topics: Amikacin; Child; Child, Preschool; Clinical Trials as Topic; Escherichia coli Infections; Female; Humans; Infant; Injections, Intramuscular; Kanamycin; Sulfisoxazole; Urinary Tract Infections | 1983 |
Short-course aminoglycoside therapy in patients with spinal cord injury. Standard dose versus low dose.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Humans; Injections, Intramuscular; Kanamycin; Proteus Infections; Providencia; Pseudomonas Infections; Random Allocation; Recurrence; Spinal Cord Injuries; Tobramycin; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1980 |
Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Gentamicins; Humans; Kanamycin; Lung Diseases; Male; Middle Aged; Netilmicin; Sepsis; Urinary Tract Infections | 1980 |
Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbapenems; Ceftazidime; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Respiratory Tract Infections; Sepsis; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections | 1995 |
Isepamicin versus amikacin in the treatment of urinary tract infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Escherichia coli Infections; Female; Follow-Up Studies; Gentamicins; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 1995 |
Overview of the efficacy of isepamicin in the adult core clinical trial programme.
Topics: Abdomen; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Drug Administration Schedule; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1995 |
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Male; Neutropenia; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections | 1997 |
[Objective audiologic assessment of children treated with amikacin].
Topics: Adolescent; Age Factors; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Hearing Loss, Functional; Hearing Tests; Humans; Infant; Male; Otoacoustic Emissions, Spontaneous; Urinary Tract Infections | 1999 |
Once daily isepamicin treatment in complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Female; Gentamicins; Humans; Male; Middle Aged; Prospective Studies; Urinary Tract Infections | 1999 |
Controlled comparison of amikacin and gentamicin.
Topics: Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Clinical Trials as Topic; Drug Evaluation; Drug Resistance, Microbial; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney; Middle Aged; Prospective Studies; Sepsis; Urinary Tract Infections | 1977 |
Treatment of complicated urinary tract infections with amikacin: comparison of low and high dosage.
Topics: Adolescent; Adult; Aged; Amikacin; Escherichia coli; Female; Humans; Kanamycin; Male; Middle Aged; Proteus; Pseudomonas; Urinary Tract Infections | 1977 |
[Comparative clinical effect of amikacin and gentamicin on complicated urinary tract infections by doubld-blind method (author's transl)].
Topics: Adult; Aged; Amikacin; Clinical Trials as Topic; Double-Blind Method; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Urinary Tract Infections | 1978 |
Comparison of netilmicin and amikacin in treatment of complicated urinary tract infections.
Topics: Adult; Aged; Amikacin; Clinical Trials as Topic; Gentamicins; Humans; Kanamycin; Kidney; Male; Middle Aged; Netilmicin; Urinary Tract Infections | 1978 |
[Amikacin and gentamicin: a controlled comparison (author's transl)].
Topics: Amikacin; Clinical Trials as Topic; Double-Blind Method; Female; Gentamicins; Humans; Kanamycin; Male; Urinary Tract Infections | 1978 |
[Clinical efficacy, nephrotoxicity and ototoxicity of amikacin].
Topics: Adult; Aged; Amikacin; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Female; Hearing; Humans; Kanamycin; Kidney; Male; Middle Aged; Time Factors; Urinary Tract Infections; Vestibule, Labyrinth | 1979 |
Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Female; Humans; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Neoplasms; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tobramycin; Urinary Tract Infections | 1977 |
[Pharmacokinetics and clinical experience with amikacin. A new aminoglycoside antibiotic].
Topics: Adult; Aged; Amikacin; Aminoglycosides; Biological Availability; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Kanamycin; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Peritonitis; Respiratory Tract Infections; Urinary Tract Infections | 1976 |
[Amikacin in urinary tract infections with so-called problem pathogens].
Topics: Amikacin; Clinical Trials as Topic; Drug Evaluation; Escherichia coli Infections; Humans; Kanamycin; Proteus Infections; Pseudomonas Infections; Urinary Tract Infections | 1976 |
Amikacin Therapy of Urinary tract infections.
Topics: Adolescent; Adult; Aged; Amikacin; Clinical Trials as Topic; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Pseudomonas Infections; Urinary Tract Infections | 1976 |
A review of results of clinical trials with amikacin.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Bone Diseases; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Kanamycin; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1976 |
Comparison of amikacin and gentamicin in the treatment of urinary tract infections.
Topics: Adolescent; Adult; Aged; Amikacin; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Prospective Studies; Pyelonephritis; Urinary Tract Infections | 1977 |
A comparative study on aztreonam, ceftazidime and amikacin in the treatment of complicated urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aztreonam; Bacterial Infections; Ceftazidime; Female; Humans; Male; Middle Aged; Prospective Studies; Urinary Tract Infections | 1991 |
Pharmacokinetic evaluation of single daily dose amikacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Child; Child, Preschool; Drug Administration Schedule; Half-Life; Humans; Middle Aged; Penicillins; Prospective Studies; Urinary Tract Infections | 1991 |
Effect and pharmacokinetics of netilmicin given as bolus intramuscular administration: an open comparative trial versus amikacin and fosfomycin in elderly patients affected by urinary tract infections.
Topics: Age Factors; Aged; Algorithms; Amikacin; Female; Fosfomycin; Humans; Injections, Intramuscular; Male; Middle Aged; Netilmicin; Urinary Tract Infections; Urine | 1991 |
Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Drug Administration Schedule; Enterobacteriaceae; Female; Gram-Negative Bacteria; Hearing; Humans; Kidney; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Respiratory Tract Infections; Serum Bactericidal Test; Urinary Tract Infections | 1991 |
[Amikacin in the treatment of genito-urinary an pulmonary infections in oncologic patients].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Middle Aged; Neoplasms; Respiratory Tract Infections; Urinary Tract Infections | 1991 |
Enzymuria in aminoglycoside-induced kidney damage. Comparative study of gentamicin, amikacin, sisomicin and netilmicin.
Topics: Adolescent; Adult; Aged; alpha-Glucosidases; Amikacin; Creatinine; Female; gamma-Glutamyltransferase; Gentamicins; Glucosidases; Humans; Kanamycin; Kidney; Male; Middle Aged; Muramidase; Netilmicin; Proteinuria; Sisomicin; Urinary Tract Infections | 1985 |
[Comparative study of first-line ceftriaxone and amikacin in the treatment of severe urinary tract infections in the adult].
Topics: Adult; Aged; Amikacin; Ceftriaxone; Drug Evaluation; Drug Tolerance; Humans; Middle Aged; Random Allocation; Urinary Tract Infections | 1987 |
Comparative study of Ro 17-2301 (AMA-1080) and amikacin in complicated urinary tract infections.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacteria; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Urinary Tract Infections | 1987 |
120 other study(ies) available for amikacin and Urinary Tract Infections
| Article | Year |
|---|---|
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.
Topics: Bacterial Typing Techniques; beta-Lactamases; Canada; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2021 |
The evaluation of antibiotic susceptibility pattern and associated risk factors of UTI in tertiary care hospital of Peshawar.
Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli; Female; Fosfomycin; Humans; Imipenem; Klebsiella pneumoniae; Linezolid; Male; Meropenem; Pseudomonas aeruginosa; Risk Factors; Tertiary Care Centers; Urinary Tract Infections; Vancomycin | 2022 |
Genotypic Detection of
Topics: Agar; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Ciprofloxacin; Citrobacter koseri; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections | 2022 |
Molecular Detection of
Topics: Amikacin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Erythromycin; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Vancomycin | 2022 |
Bacterial profile, antimicrobial resistance, and molecular detection of ESBL and quinolone resistance gene of uropathogens causing urinary tract infection in the southeastern part of Bangladesh.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bangladesh; beta-Lactamases; Cefazolin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; RNA, Ribosomal, 16S; Urinary Tract Infections | 2023 |
Characteristics of and antibiotic resistance in urinary tract pathogens isolated from patients with upper urinary tract stones.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Piperacillin; Sulbactam; Tazobactam; Urinary Calculi; Urinary Tract; Urinary Tract Infections | 2023 |
CpxA/R-Controlled Nitroreductase Expression as Target for Combinatorial Therapy against Uropathogens by Promoting Reactive Oxygen Species Generation.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Proteins; Humans; Nitrofurantoin; Nitroreductases; Protein Kinases; Reactive Oxygen Species; Urinary Tract Infections | 2023 |
Antibiotic Guidelines for Critically Ill Patients in Nigeria.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Community-Acquired Infections; Critical Illness; Cross Infection; Fluconazole; Humans; Meropenem; Microbial Sensitivity Tests; Nigeria; Piperacillin, Tazobactam Drug Combination; Pneumonia; Prospective Studies; Urinary Tract Infections | 2023 |
Genomic analysis of two drug-resistant clinical Morganella morganii strains isolated from UTI patients in Pretoria, South Africa.
Topics: Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Genome, Bacterial; Genomics; Humans; Integrons; Male; Microbial Sensitivity Tests; Middle Aged; Morganella morganii; Phylogeny; Plasmids; South Africa; Urinary Tract Infections | 2020 |
In-Vitro Biofilm Formation and Antimicrobial Resistance of
Topics: Adolescent; Adult; Aged; Amikacin; Amoxicillin; Anti-Bacterial Agents; Biofilms; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Uropathogenic Escherichia coli; Young Adult | 2019 |
An
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Synergism; Escherichia coli; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Urinary Tract Infections | 2019 |
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2020 |
Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Urinary Tract Infections; Virulence Factors | 2020 |
Impact of Therapeutic Drug Monitoring on Once-Daily Regimen of Amikacin in Patients With Urinary Tract Infection: A Prospective Observational Study.
Topics: Amikacin; Anti-Bacterial Agents; Drug Monitoring; Humans; Prospective Studies; Urinary Tract Infections | 2020 |
Nitrofurantoin Combined With Amikacin: A Promising Alternative Strategy for Combating MDR Uropathogenic
Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli Infections; Humans; Nitrofurantoin; Urinary Tract Infections; Uropathogenic Escherichia coli | 2020 |
Aminoglycosides Monotherapy as First-Line Treatment for Febrile Urinary Tract Infection in Children.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fever; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract Infections | 2017 |
Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Female; Gene Expression Regulation, Bacterial; Hospitalization; Humans; Iran; Isoenzymes; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Urinary Tract Infections | 2018 |
Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Imipenem; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Tazobactam; Urinary Tract Infections; Young Adult | 2017 |
Management of urinary tract infection with intravesical amikacin may increase the risk of bladder oxidative stress in children with neurogenic bladder.
Topics: Administration, Intravesical; Amikacin; Anti-Bacterial Agents; Biomarkers; Child; Child, Preschool; Female; Glutathione; Humans; Male; Oxidative Stress; Prospective Studies; Urinary Bladder, Neurogenic; Urinary Tract Infections | 2017 |
Trend of Antibiotic Sensitivity of Escherichia Coli in Patients with Urinary Tract Infection.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Urinary Tract Infections; Young Adult | 2017 |
[Antimicrobial susceptibility of bacteria causing urosepsis].
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Blood Culture; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis; Ureterolithiasis; Urinary Tract Infections; Young Adult | 2017 |
Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fever; France; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Prospective Studies; Risk Factors; Urinary Tract Infections | 2018 |
Amikacin Monotherapy for Treatment of Febrile Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-producing Escherichia coli in Children.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Child; Escherichia coli; Humans; Urinary Tract Infections | 2018 |
Mycobacterium abscessus urinary tract infection: case report.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Treatment Outcome; Urinary Tract Infections | 2020 |
Antibiotic treatment and antimicrobial resistance in children with urinary tract infections.
Topics: Administration, Intravenous; Adolescent; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antimicrobial Stewardship; Child; Child, Preschool; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Fever; Greece; Humans; Infant; Infant, Newborn; Klebsiella; Male; Retrospective Studies; Urinary Tract Infections | 2020 |
Uropathogens and antibiotic resistance in the community and hospital-induced urinary tract infected children.
Topics: Adolescent; Amikacin; Ampicillin; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Infant; Infant, Newborn; Inpatients; Klebsiella; Male; Microbial Sensitivity Tests; Outpatients; Proteus; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections | 2020 |
The Role of Ciprofloxacin Resistance and Extended-spectrum beta-lactamase (ESBL) Positivity in Infective Complications Following Prostate Biopsy.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactamases; Biopsy; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Male; Middle Aged; Needs Assessment; Nitrofurantoin; Prostatic Neoplasms; Rectum; Urinary Tract Infections | 2020 |
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Female; Gram-Negative Bacteria; Humans; Imipenem; Inpatients; Male; United States; Urinary Tract Infections | 2013 |
Urinary tract infections in patients with orthotopic neobladder.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cohort Studies; Cystectomy; Escherichia coli; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Patient Discharge; Postoperative Complications; Proportional Hazards Models; Pseudomonas aeruginosa; Tertiary Care Centers; Urinary Bladder; Urinary Diversion; Urinary Reservoirs, Continent; Urinary Tract Infections | 2014 |
Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult | 2014 |
Intravesical instillation of amikacin for treatment of a lower urinary tract infection caused by Pseudomonas aeruginosa in a dog.
Topics: Administration, Intravesical; Amikacin; Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Female; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 2014 |
Frequency distribution of genes encoding aminoglycoside modifying enzymes in uropathogenic E. coli isolated from Iranian hospital.
Topics: Amikacin; Anti-Bacterial Agents; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gene Frequency; Genes, Bacterial; Gentamicins; Hospitals, Teaching; Humans; Iran; Kanamycin; Netilmicin; Tobramycin; Urinary Tract Infections; Uropathogenic Escherichia coli | 2014 |
Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftazidime; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Infant; Male; Pilot Projects; Recurrence; Retrospective Studies; Taiwan; Urinary Tract Infections; Vesico-Ureteral Reflux | 2016 |
Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cohort Studies; Critical Illness; Female; Gentamicins; Humans; Intraabdominal Infections; Male; Middle Aged; Plasma; Pneumonia, Bacterial; Urinary Tract Infections | 2015 |
Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Topics: Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Japan; Klebsiella oxytoca; Klebsiella pneumoniae; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections; Vancomycin | 2015 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Urinary Tract Infection among Renal Transplant Recipients in Yemen.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Escherichia coli; Female; Humans; Kidney Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Staphylococcus saprophyticus; Transplant Recipients; Urinary Tract Infections; Yemen; Young Adult | 2015 |
Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Amikacin; beta-Lactamase Inhibitors; beta-Lactamases; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome; Urinalysis; Urinary Tract Infections; Urine | 2016 |
[Characterization of class 1 and class 2 integron gene cassettes in Escherichia coli strains isolated from urine cultures: a multicenter study].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Escherichia coli Infections; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2016 |
Colistin-resistant Enterobacteriaceae infections: clinical and molecular characterization and analysis of in vitro synergy.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia; Prospective Studies; Soft Tissue Infections; Tigecycline; Urinary Tract Infections | 2017 |
Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Gentamicins; Humans; Middle Aged; RNA, Ribosomal, 16S; Urinary Tract Infections | 2017 |
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections | 2017 |
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters, Indwelling; Cross Infection; Cystectomy; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospital Units; Humans; Immunosuppression Therapy; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Surgical Wound Infection; Urinary Catheters; Urinary Tract Infections; Urology; Vancomycin | 2017 |
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections | 2017 |
Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006.
Topics: Adolescent; Amikacin; Ampicillin; Analysis of Variance; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Male; Microbial Sensitivity Tests; Probability; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Turkey; Urinalysis; Urinary Tract Infections; Urine | 2009 |
Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Biopsy, Needle; Chi-Square Distribution; Drug Therapy, Combination; Fluoroquinolones; Humans; Male; Middle Aged; Postoperative Complications; Prostate; Prostatic Diseases; Treatment Outcome; Urinary Tract Infections | 2011 |
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Topics: Amikacin; Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies; Urinary Tract Infections | 2012 |
Antibiotic resistance of bacteria associated with community-acquired urinary tract infections in the southern area of the Gaza Strip.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle East; Urinary Tract Infections | 2002 |
[Cefepime (maxipime) in the treatment of severe urinary tract infection].
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Sensitivity and Specificity; Treatment Outcome; Urinary Tract Infections | 2003 |
Increasing prevalence of antibiotic resistance and multi drug resistance among uropathogens.
Topics: Adolescent; Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Multiple; Escherichia coli; Female; Gentamicins; Humans; India; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2003 |
Intramuscular antibiotic treatment of urinary tract infection.
Topics: Amikacin; Analysis of Variance; Anti-Infective Agents, Urinary; Ceftriaxone; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Injections, Intramuscular; Male; Probability; Prospective Studies; Severity of Illness Index; Treatment Outcome; Turkey; Urinalysis; Urinary Tract Infections | 2004 |
Amikacin--single dose treatment for uncomplicated urinary tract infections in children.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Male; Sex Characteristics; Treatment Outcome; Urinary Tract Infections | 1989 |
Hypotonia during amikacin administration in a patient treated with continuous ambulatory peritoneal dialysis.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Female; Humans; Hypotension; Peritoneal Dialysis, Continuous Ambulatory; Urinary Tract Infections | 2006 |
Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Topics: Adolescent; Age Factors; Amikacin; Ampicillin; Antibiotic Prophylaxis; Bacterial Infections; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Female; Gentamicins; Humans; Infant; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections | 2006 |
Influence of subinhibitory concentrations of amikacin and ciprofloxacin on morphology and adherence ability of uropathogenic strains.
Topics: Amikacin; Anti-Infective Agents; Bacterial Adhesion; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Epithelial Cells; Female; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microscopy, Phase-Contrast; Urinary Tract Infections | 2007 |
Uropathogens and empiric antibiotics for the treatment of urinary tract infections in spinal cord injured patients at rehabilitation center, Thai Red Cross Society during 2001 to 2005.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cephalosporins; Escherichia coli Infections; Female; Health Status Indicators; Humans; Length of Stay; Male; Prevalence; Red Cross; Rehabilitation Centers; Retrospective Studies; Sickness Impact Profile; Societies, Medical; Spinal Cord Injuries; Thailand; Urinary Tract Infections | 2007 |
Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece.
Topics: Adolescent; Adult; Amikacin; Ampicillin Resistance; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Greece; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Primary Health Care; Retrospective Studies; Urinary Tract Infections | 2008 |
[In vitro activity of cefotaxime (HR 756) compared with cephalexin, gentamycin and amikacin against Gram-negative bacteria and urinary infections].
Topics: Amikacin; Cefotaxime; Cephalexin; Enterobacteriaceae; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Urinary Tract Infections | 1983 |
Amikacin, gentamicin and tobramycin resistant Pseudomonas aeruginosa in a leukaemic ward. Epidemiology and genetic studies.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Female; Gentamicins; Humans; Leukemia; Male; Middle Aged; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Urinary Tract Infections | 1982 |
[Our experience with sodium cefoperazone].
Topics: Amikacin; Cefoperazone; Drug Synergism; Escherichia coli Infections; Humans; Meningitis; Pseudomonas Infections; Urinary Tract Infections | 1984 |
[Comparative study and time changes in the resistance to gentamycin, tobramycin, sisomicin and amikacin of Gram-negative nosocomial bacterial strains isolated from the urinary tract, in relation to the annual use of the aminoglycosides tested].
Topics: Amikacin; Cross Infection; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Sisomicin; Tobramycin; Urinary Tract Infections | 1983 |
Treatment of gentamicin-resistant Klebsiella urinary tract infections with cephradine, augmentin, cefuroxime and amikacin.
Topics: Adult; Aged; Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephradine; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Combinations; Female; Gentamicins; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Urinary Tract Infections | 1981 |
Netilmicin treatment of complicated urinary tract infections.
Topics: Aged; Amikacin; Gentamicins; Humans; Kinetics; Male; Middle Aged; Netilmicin; Tobramycin; Urinary Tract Infections | 1980 |
[Single daily dose of amikacin in the treatment of urinary tract infections].
Topics: Adolescent; Adult; Aged; Amikacin; Drug Resistance, Microbial; Female; Humans; In Vitro Techniques; Kanamycin; Male; Middle Aged; Urinary Tract Infections | 1980 |
[Evaluation of amikacin intravenous therapy in pediatrics (author's transl)].
Topics: Adolescent; Age Factors; Amikacin; Blood Urea Nitrogen; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Infusions, Parenteral; Injections, Intravenous; Kanamycin; Liver; Male; Urinary Tract Infections; Whooping Cough | 1980 |
[Experience with intravenous drip infusion of amikacin in urological field (author's transl)].
Topics: Adult; Aged; Amikacin; Drug Evaluation; Female; Humans; Infusions, Parenteral; Kanamycin; Male; Middle Aged; Urinary Tract Infections | 1981 |
Control and duration of therapy in complicated UTI--with special consideration of C-reactive protein.
Topics: Amikacin; C-Reactive Protein; Drug Administration Schedule; Drug Therapy, Combination; Escherichia coli; Female; Humans; Mezlocillin; Middle Aged; Urinary Tract Infections | 1994 |
[Cutaneous necroses after subcutaneous injections of amikacin].
Topics: Aged; Aged, 80 and over; Amikacin; Female; Humans; Injections, Subcutaneous; Necrosis; Skin; Urinary Tract Infections | 1993 |
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries | 1997 |
[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; beta-Lactamases; Child; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillin Resistance; Penicillins; Streptomycin; Urinary Tract Infections; Vancomycin | 1998 |
[Importance of the association ticarcillin-clavulanic acid-amikacin in the treatment of severe urinary infections after major urodigestive surgery. Report of 59 cases].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Clavulanic Acid; Cross Infection; Digestive System Surgical Procedures; Drug Therapy, Combination; Humans; Middle Aged; Postoperative Care; Ticarcillin; Urinary Tract Infections; Urologic Surgical Procedures | 1998 |
Ceftriaxone-induced haemolytic anaemia in a child with no immune deficiency or haematological disease.
Topics: Amikacin; Anemia, Hemolytic; Antigen-Antibody Complex; Ceftriaxone; Cephalosporins; Child, Preschool; Drug Therapy, Combination; Female; Humans; Methylprednisolone; United States; Urinary Tract Infections | 2002 |
Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
Topics: Adult; Aged; Amikacin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Serratia marcescens; Urinary Tract Infections | 1977 |
Experience with amikacin and colistin in an outbreak of infection by resistant Klebsiella aerogenes.
Topics: Aged; Amikacin; Colistin; Cross Infection; Disease Outbreaks; Drug Administration Schedule; Drug Resistance, Microbial; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Urinary Tract Infections | 1977 |
Amikacin in gram-negative paediatric infections.
Topics: Adolescent; Amikacin; Bacterial Infections; Child; Child, Preschool; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Infant; Infant, Newborn; Kanamycin; Klebsiella Infections; Male; Respiratory Tract Infections; Skin Diseases; Urinary Tract Infections | 1978 |
[Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)].
Topics: Adult; Aged; Amikacin; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Kanamycin; Male; Middle Aged; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections | 1977 |
Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; In Vitro Techniques; Infant; Kanamycin; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Serratia marcescens; Urinary Tract Infections | 1978 |
Clinical evaluation of netilmicin therapy in serious infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Netilmicin; Sepsis; Urinary Tract Infections | 1979 |
[Treatment of hospital-acquired urinary infections with amikacin (author's transl)].
Topics: Amikacin; Cross Infection; Drug Evaluation; Drug Resistance, Microbial; Female; Hearing Disorders; Humans; Kanamycin; Male; Middle Aged; Urinary Tract Infections | 1979 |
[Serum levels in the surveillance of treatment with amikacin in urology].
Topics: Amikacin; Humans; Kanamycin; Kinetics; Urinary Tract Infections | 1979 |
[Therapeutic effect of amikacin for infections with gram-negative bacilli, especially for stubborn respiratory infections (author's transl)].
Topics: Adult; Aged; Amikacin; Bronchiectasis; Chronic Disease; Drug Evaluation; Empyema; Female; Humans; Kanamycin; Lung Neoplasms; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Tuberculosis, Pulmonary; Urinary Tract Infections | 1978 |
Antimicrobial therapy in the neonate.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Meningitis; Penicillins; Skin Diseases, Infectious; Tobramycin; Urinary Tract Infections | 1978 |
[Clinical experience with amikacin for chronic complicated urinary tract infections in myelopathogenic bladder. Clinical effect against gentamicin-resistant bacteria (author's transl)].
Topics: Adult; Aged; Amikacin; Chronic Disease; Drug Evaluation; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Spinal Cord Injuries; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1978 |
[New antibiotics in the treatment of urinary tract infections].
Topics: Amikacin; Amoxicillin; Ampicillin; Carbenicillin; Humans; Kanamycin; Pivampicillin; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 1978 |
Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Bronchitis; Chronic Disease; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 1976 |
Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
Topics: Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Bacterial Infections; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1976 |
Use of Amikacin in a hospital for children: microbiological and clinical studies.
Topics: Amikacin; Aminoglycosides; Bacterial Infections; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Kanamycin; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1976 |
Treatment of hospita-acquired infections with amikacin.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cross Infection; Female; Humans; Kanamycin; Male; Middle Aged; Proteus; Proteus Infections; Urinary Tract Infections | 1977 |
[New drugs: Amikacin].
Topics: Adult; Amikacin; Child; Drug Therapy, Combination; Humans; Infant, Newborn; Kanamycin; Respiratory Tract Infections; Skin Diseases, Infectious; Urinary Tract Infections | 1976 |
Amikacin in treatment of infections caused by gram-negative bacteria resistant to gentamicin and other aminoglycosides: clinical and bacteriologic results.
Topics: Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kanamycin; Male; Micrococcus; Middle Aged; Respiratory Tract Infections; Urinary Tract Infections | 1976 |
Pharmacokinetics of amikacin for treatment of urinary tract infections in patients with reduced renal function.
Topics: Aged; Amikacin; Chronic Disease; Drug Evaluation; Glomerular Filtration Rate; Half-Life; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Urinary Tract Infections | 1976 |
Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies.
Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fetal Blood; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Kidney Failure, Chronic; Pregnancy; Pregnancy Complications, Infectious; Pseudomonas Infections; Urinary Tract Infections | 1976 |
Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Chronic Disease; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Peritonitis; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1976 |
Amikacin pharmacokinetics in the therapy of childhood urinary tract infection.
Topics: Amikacin; Child; Child, Preschool; Female; Humans; Kanamycin; Recurrence; Urinary Tract Infections | 1976 |
Multidrug-resistant Proteus rettgeri: an emerging problem.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cephalothin; Cross Infection; Gentamicins; Humans; Kanamycin; Penicillin Resistance; Proteus; Proteus Infections; R Factors; Urinary Tract Infections | 1976 |
Amikacin therapy for serious gram-negative bacillary infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Ear, Inner; Female; Humans; Kanamycin; Kidney; Male; Middle Aged; Osteomyelitis; Peritonitis; Pneumonia; Sepsis; Urinary Tract Infections | 1975 |
[Study of the increasing effect of therapeutic efficacy of amikacin in combination with human granulocyte-colony stimulating factor (G-CSF) against experimental urinary tract infection in diabetic mice].
Topics: Amikacin; Animals; Anti-Infective Agents, Urinary; Diabetes Mellitus, Experimental; Drug Evaluation; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Mice; Mice, Inbred Strains; Pseudomonas Infections; Urinary Tract Infections | 1991 |
[In vitro sensitivity of gram-negative bacteria isolated from urinary tract infections to various antibiotics].
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftazidime; Clavulanic Acids; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacteria; Humans; Klebsiella; Ofloxacin; Piperacillin; Proteus; Pseudomonas; Turkey; Urinary Tract Infections | 1991 |
[Amikacin in the treatment of infectious-inflammatory diseases in patients at a therapeutic hospital].
Topics: Amikacin; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Endocarditis, Bacterial; Humans; Inflammation; Respiratory Tract Infections; Urinary Tract Infections | 1990 |
[An epidemiologic study of the antibiotic susceptibility of bacteria isolated from patients with urinary tract infections].
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Ofloxacin; Prevalence; Turkey; Urinary Tract Infections | 1989 |
[Infectious complications after surgery of esophageal pathology. Apropos of 60 cases].
Topics: Aged; Amikacin; Bacterial Infections; Cefoxitin; Esophageal Diseases; Female; Gram-Negative Bacteria; Humans; Lung Diseases; Male; Middle Aged; Parenteral Nutrition; Postoperative Complications; Premedication; Prospective Studies; Urinary Tract Infections | 1989 |
[Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cephamycins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Leukemia; Male; Middle Aged; Respiratory Tract Infections; Urinary Tract Infections | 1989 |
Massive hemothorax and Groshong catheters.
Topics: Adult; Amikacin; Catheterization, Central Venous; Ceftazidime; Hemothorax; Humans; Male; Pseudomonas Infections; Subclavian Vein; Urinary Tract Infections | 1989 |
Effect of netilmicin and amikacin on urinary phospholipids excretion in humans.
Topics: Amikacin; Female; Humans; Male; Netilmicin; Pelvic Inflammatory Disease; Phospholipids; Time Factors; Urinary Tract Infections | 1989 |
Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.
Topics: Amikacin; beta-Lactamases; Cefotaxime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Paris; Recurrence; Urinary Tract Infections | 1987 |
Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin.
Topics: Acinetobacter; Amikacin; Bacteria; Corynebacterium; Enterococcus faecalis; Humans; Infusions, Intravenous; Kinetics; Klebsiella pneumoniae; Listeria monocytogenes; Microbial Sensitivity Tests; Nontuberculous Mycobacteria; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus; Staphylococcus epidermidis; Urinary Tract Infections | 1987 |
Effects of single-dose and three-day trimethoprim-sulfadiazine and amikacin treatment of induced Escherichia coli urinary tract infections in dogs.
Topics: Amikacin; Animals; Anti-Infective Agents, Urinary; Bacteriuria; Dog Diseases; Dogs; Drug Administration Schedule; Drug Combinations; Escherichia coli Infections; Female; Male; Random Allocation; Sulfadiazine; Trimethoprim; Urinary Tract Infections | 1988 |
[Clinical and bacteriological study of O-demethylfortimicin A sulfate in urinary infection].
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tobramycin; Urinary Tract Infections | 1986 |
[Clinical evaluation of combination therapy with cefoxitin and amikacin in complicated urinary tract infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Cefoxitin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1986 |
[Investigation on the use of amikacin in the newborn].
Topics: Amikacin; Animals; Humans; Infant; Infant, Newborn; Male; Rabbits; Urinary Tract Infections | 1987 |
Management of sepsis in the elderly.
Topics: Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pneumonia; Risk; Shock, Septic; Urinary Tract Infections | 1986 |
Upper and lower urinary tract infections: amikacin's role in managing surgical complications.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Humans; Kanamycin; Postoperative Complications; Premedication; Risk; Surgical Wound Infection; Urinary Catheterization; Urinary Tract Infections | 1986 |
Cefsulodin in treatment of Pseudomonas urinary tract infection in patients with spinal cord injury. Comparison with aminoglycosides.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefsulodin; Humans; Male; Middle Aged; Pseudomonas Infections; Spinal Cord Injuries; Time Factors; Tobramycin; Urinary Tract Infections | 1986 |
Single-shot vs conventional therapy with amikacin for treatment of uncomplicated urinary tract infections: a multicenter study.
Topics: Adolescent; Adult; Age Factors; Aged; Amikacin; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Male; Middle Aged; Sex Factors; Urinary Tract Infections | 1986 |
Overview of first-line amikacin therapy for urologic infections.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Kidney Diseases; Lactams; Sepsis; Urinary Tract Infections | 1985 |
Bilateral and symmetrical osteomyelitis due to gram-negative bacilli. A report on two cases.
Topics: Adult; Amikacin; Ampicillin; Female; Gram-Negative Bacteria; Humans; Middle Aged; Osteomyelitis; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 1985 |
Antibiotic treatment of complicated urologic infections. Six selected case studies.
Topics: Adult; Aged; Amikacin; Combined Modality Therapy; Diabetes Mellitus, Type 1; Female; Gangrene; Genital Diseases, Male; Humans; Ileum; Kanamycin; Kidney; Male; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Scrotum; Urinary Calculi; Urinary Diversion; Urinary Fistula; Urinary Tract Infections | 1985 |
[Study of the local use of amikacin].
Topics: Adult; Aged; Amikacin; Anti-Infective Agents, Urinary; Catheters, Indwelling; Drug Evaluation; Female; Humans; Kanamycin; Male; Middle Aged; Urinary Tract Infections | 1985 |